Treatments | CT, log10 CFU/g | FITC-d, ng/mL |
---|---|---|
 | Trial 1 | |
CTRL (−) | 0.00 ± 0.00 d | 17.03 ± 5.44 b |
CTRL (+) | 6.18 ± 0.33 a | 54.99 ± 10.51 a |
CA | 4.99 ± 0.32 b | 35.19 ± 8.80 ab |
CR | 3.92 ± 0.55 bc | 17.60 ± 7.50 b |
CA-CR | 3.76 ± 0.54 c | 32.99 ± 10.34 ab |
SEM3 | 0.33 | 4.18 |
P-value | 0.000 | 0.020 |
 | Trial 2 | |
CTRL (−) | 0.00 ± 0.00 d | 19.80 ± 9.26 b |
CTRL (+) | 6.09 ± 0.276 a | 59.38 ± 9.81 a |
CA | 4.94 ± 0.32 b | 32.99 ± 11.31 ab |
CR | 3.91 ± 0.19 c | 15.40 ± 7.60 b |
CA-CR | 3.78 ± 0.31 c | 39.59 ± 15.06 ab |
SEM3 | 0.30 | 5.13 |
P-value | 0.000 | 0.048 |